Teillaud JL - Search Results

1

Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells.

Barrio MM, Abes R, Colombo M, Pizzurro G, Boix C, Roberti MP, Gélizé E, Rodriguez-Zubieta M, Mordoh J, Teillaud JL. Barrio MM, et al. Among authors: teillaud jl. PLoS One. 2012;7(7):e40311. doi: 10.1371/journal.pone.0040311. Epub 2012 Jul 2. PLoS One. 2012. PMID: 22768350 Free PMC article.

2

High lipid content of irradiated human melanoma cells does not affect cytokine-matured dendritic cell function.

Pizzurro GA, Madorsky Rowdo FP, Pujol-Lereis LM, Quesada-Allué LA, Copati AM, Roberti MP, Teillaud JL, Levy EM, Barrio MM, Mordoh J. Pizzurro GA, et al. Among authors: teillaud jl. Cancer Immunol Immunother. 2013 Jan;62(1):3-15. doi: 10.1007/s00262-012-1295-4. Epub 2012 Jun 22. Cancer Immunol Immunother. 2013. PMID: 22722447 Free PMC article.

3

CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells.

Mantegazza AR, Barrio MM, Moutel S, Bover L, Weck M, Brossart P, Teillaud JL, Mordoh J. Mantegazza AR, et al. Among authors: teillaud jl. Blood. 2004 Aug 15;104(4):1183-90. doi: 10.1182/blood-2004-01-0104. Epub 2004 May 6. Blood. 2004. PMID: 15130945 Free article.

4

Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response.

Abès R, Gélizé E, Fridman WH, Teillaud JL. Abès R, et al. Among authors: teillaud jl. Blood. 2010 Aug 12;116(6):926-34. doi: 10.1182/blood-2009-10-248609. Epub 2010 May 3. Blood. 2010. PMID: 20439625 Free article.

5

Modulation of tumor immunity by therapeutic monoclonal antibodies.

Abès R, Teillaud JL. Abès R, et al. Among authors: teillaud jl. Cancer Metastasis Rev. 2011 Mar;30(1):111-24. doi: 10.1007/s10555-011-9282-3. Cancer Metastasis Rev. 2011. PMID: 21267767 Review.

6

Impact of Glycosylation on Effector Functions of Therapeutic IgG.

Abès R, Teillaud JL. Abès R, et al. Among authors: teillaud jl. Pharmaceuticals (Basel). 2010 Jan 12;3(1):146-157. doi: 10.3390/ph3010146. Pharmaceuticals (Basel). 2010. PMID: 27713246 Free PMC article. Review.

7

[Antibodies: better knowledge for a better use].

Abès R, Dutertre CA, Teillaud JL. Abès R, et al. Among authors: teillaud jl. Med Sci (Paris). 2009 Dec;25(12):1011-9. doi: 10.1051/medsci/200925121011. Med Sci (Paris). 2009. PMID: 20035672 Free article. Review. French.

8

Activating and inhibitory Fcgamma receptors in immunotherapy: being the actor or being the target.

Abès R, Dutertre CA, Agnelli L, Teillaud JL. Abès R, et al. Among authors: teillaud jl. Expert Rev Clin Immunol. 2009 Nov;5(6):735-47. doi: 10.1586/eci.09.57. Expert Rev Clin Immunol. 2009. PMID: 20477693

9

Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells.

Behar G, Sibéril S, Groulet A, Chames P, Pugnière M, Boix C, Sautès-Fridman C, Teillaud JL, Baty D. Behar G, et al. Among authors: teillaud jl. Protein Eng Des Sel. 2008 Jan;21(1):1-10. doi: 10.1093/protein/gzm064. Epub 2007 Dec 11. Protein Eng Des Sel. 2008. PMID: 18073223

10

Single-domain antibody-based and linker-free bispecific antibodies targeting FcγRIII induce potent antitumor activity without recruiting regulatory T cells.

Rozan C, Cornillon A, Pétiard C, Chartier M, Behar G, Boix C, Kerfelec B, Robert B, Pèlegrin A, Chames P, Teillaud JL, Baty D. Rozan C, et al. Among authors: teillaud jl. Mol Cancer Ther. 2013 Aug;12(8):1481-91. doi: 10.1158/1535-7163.MCT-12-1012. Epub 2013 Jun 11. Mol Cancer Ther. 2013. PMID: 23757164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page